is saxenda a glp-1 medication (liraglutide) for Weight Loss Saxenda (liraglutide): Uses, Side Effects,
Description
Elina A
In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk
[DOI] [PMC free article] [PubMed] [Google Scholar] 247.Li L, Shen J, Bala MM, et al
It lives inside Labs & Scans, next to your weight
